financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Nutanix, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Nutanix, Inc.
Mar 4, 2024 11:01 PM

01:00 PM EST, 02/29/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our target to $71 from $47 on a P/S of 7.5x, above its three-year average on good sales execution and a favorable deal pipeline, using our next-12-month sales estimate of $2.3B. We lift our FY 24 EPS view to $1.07 from $0.95 and FY 25's to $1.33 from $1.21. NTNX posted Q2 sales of $565.2M, above consensus by $14.8M, while non-GAAP EPS of $0.46 beat by $0.17. Revenue rose 16.2% Y/Y from solid Subscription revenue growth (+18% Y/Y) as ACV billings outperformed, up 23% Y/Y, from higher-than-anticipated renewals. We note NTNX's commentary around a continued uncertain macro environment, and longer average sales cycles, which likely impacted contract duration of 2.8 years in Q2, lower than Q1. However, these results reflect the firm's strong execution in securing and keeping pace with renewals and expansion deals, as well as maintaining healthy pricing levels in spite of these challenges. Its upbeat guidance and a higher mix of large deals in the pipeline further support our positive view of the business.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Morgan Stanley
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Morgan Stanley
May 26, 2025
12:35 PM EDT, 05/21/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price by $12 to $147, reflecting a wider risk premium to global market uncertainties and a forward P/E multiple at 16.5x compared to the five-year...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Target Corporation
Research Alert: CFRA Keeps Hold Opinion On Shares Of Target Corporation
May 26, 2025
03:30 PM EDT, 05/21/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We trim our 12-month target by $1 to $99, 12x our FY 27 (Jan.) EPS estimate of $8.22 (up from $7.69 to reflect the shift of tariff containment to FY...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Medtronic Plc
Research Alert: CFRA Keeps Buy Opinion On Shares Of Medtronic Plc
May 26, 2025
12:15 PM EDT, 05/21/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month target price of $99, 17.7x our FY 26 EPS (Apr.) estimate, a small premium to MDT's historical forward average due to our expectation of margin expansion....
Research Alert: CFRA Raises Price Target On Shares Of Tjx Companies And Maintains Sell Opinion
Research Alert: CFRA Raises Price Target On Shares Of Tjx Companies And Maintains Sell Opinion
May 26, 2025
12:25 PM EDT, 05/21/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month price target by $8 to $110, based on 24.5x our FY 26 (Jan.) EPS estimate and above the company's three-year average forward P/E multiple of 23.7x....
Copyright 2023-2026 - www.financetom.com All Rights Reserved